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Abstract
As a part of the ELIXIR-EXCELERATE efforts in capacity building, we present
here 10 steps to facilitate researchers getting started in genome assembly and
genome annotation. The guidelines given are broadly applicable, intended to
be stable over time, and cover all aspects from start to finish of a general
assembly and annotation project.
Intrinsic properties of genomes are discussed, as is the importance of using
high quality DNA. Different sequencing technologies and generally applicable
workflows for genome assembly are also detailed. We cover structural and
functional annotation and encourage readers to also annotate transposable
elements, something that is often omitted from annotation workflows. The
importance of data management is stressed, and we give advice on where to
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importance of data management is stressed, and we give advice on where to
submit data and how to make your results Findable, Accessible, Interoperable,
and Reusable (FAIR).
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Introduction
The advice here presented is based on a need seen while 
working in the ELIXIR-EXCELERATE task “Capacity Building 
in Genome Assembly and Annotation”. In this capacity we have 
held courses and workshops in several European countries and 
have encountered many users in need of a document to sup-
port them when they plan and execute their projects. With these 
10 steps we aim to fill this need.
In a de novo genome assembly and annotation project, 
the nucleotide sequence of a genome is first assembled, as 
completely as possible, and then annotated. The annotation 
process infers the structure and function of the assembled 
sequences. Protein-coding genes are often annotated first, but 
other features, such as non-coding RNAs or presence of regulatory 
or repetitive sequences, can also be annotated.
With the advances in sequencing technologies it has 
become much more feasible, and affordable, to assemble and 
annotate the genomic sequence of most organisms, includ-
ing large eukaryote genomes1,2. However, high quality genome 
assembly and annotation still represent a major challenge. Con-
siderable time and computational resources are often needed, and 
researchers have to be prepared to provide these resources 
in order to be successful. Assembly and annotation of small 
genomes e.g., bacterias and fungi, can often be performed with 
fairly small resources and a limited time commitment, but eukary-
otic genome projects often take months or even years to fin-
ish, especially when no reference genomes can be used for these 
tasks. The mere running of assembly or annotation tools can take 
several weeks (see Section 3 for examples).
Considering the amount of time, knowledge, and resources 
required by these projects, an early question you need to 
ask yourself is: “Do I really need an assembled and annotated 
genome?” In many cases an assembled transcriptome, or per-
haps a re-sequencing approach based on the genomic sequence 
of a related species, can be enough to answer your scientific 
questions. These two approaches both constitute solutions requir-
ing much less resources, both in amount of sequencing data 
needed and in regards to compute hours, but are more limited 
and do not offer as many possibilities as an annotated genome 
does. In the event that a genome draft has a significant added 
value to address the problem, one should consider whether 
sufficient financial and computational resources are available to 
produce a genome of satisfactory quality.
For those that indeed have decided to embark upon 
a genome assembly and/or annotation project, we provide, 
here, a set of good practices intended to facilitate the project 
completion. The target audience is someone entering this field 
for the first time, and we strive to answer his/her beginner 
questions. We split the information up into different sections for 
the reader to easily find the parts that are of their particular interest. 
The guidelines are meant to be broadly applicable to multiple 
software pipelines and sequencing technologies and do not 
focus on specifics, as the field is rapidly changing and discussion 
on current tools could quickly become outdated.
A checklist of things to keep in mind when starting a genome 
project:
•     For the DNA extraction, select an individual which is 
a good representative of the species, and able to provide 
enough DNA.
•     Extract more DNA than you think you need, or save 
tissue to use for DNA extraction later. If you need to 
produce more data later, it is critical to be able to use the 
same DNA to make sure the data assembles together.
•    Remember to extract RNA and order RNA-sequencing 
if you want to use assembled transcripts in your annotation 
(which is strongly recommended). If possible, extract 
RNA from the same individual as used in the DNA extraction 
to make sure that the RNA-seq reads will map well to 
your assembly.
•     Decide early on which sequencing technology you 
will be using, and also consider which assembly tools 
you want to try. These two choices will greatly influence 
what kind of compute resources you will need, and you 
do not want to end in a situation where you have data that 
you cannot analyze anywhere. Plan compute resources 
accordingly.
1. Investigate the properties of the genome you study
Every assembly or annotation project is different. Distinctive 
properties of the genome are the main reason behind this. 
To get an idea of the complexity of an assembly or annotation 
project, it is worth looking into these properties before starting. 
Here, we will discuss some genome properties, and how they 
influence the type and amount of data needed, as well as the 
complexity of analyses.
Genome size
To assemble a genome, a certain amount of sequences 
(also called reads) is needed. For example, for Illumina 
sequencing (see Illumina Genome Assembly below), a number 
of >60x sequence depth is often mentioned. This means that 
the number of total nucleotides in the reads need to be at least 
60 times the number of nucleotides in the genome. From this it 
follows that the bigger the genome, the more data is needed. 
You need to get an estimate of the genome size before ordering 
sequence data, perhaps from flow cytometry studies, or if no 
better data exists, by investigating what is the genome size of 
closely related and already assembled species. This is an impor-
tant value to bring to the sequencing facility, as the genome 
size will greatly influence the amount of data that needs to be 
ordered. Available databases for approximate genome sizes 
are available for plants (http://data.kew.org/cvalues), for fungi 
(http://www.zbi.ee/fungal-genomesize), and for animals (http://
www.genomesize.com).
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Repeats
Repeats are regions of the genome that occur in multiple 
copies, potentially at different locations in the genome. Amount 
and distribution of repeats in a genome hugely influences 
the genome assembly results, simply because reads from 
these different repeats are very similar, and the assem-
bly tools cannot distinguish between them. This can lead to 
mis-assemblies, where regions that are distant in the genome 
are assembled together, or an incorrect estimate of the size 
or number of copies of the repeats themselves3. Very often 
a high repeat content leads to a fragmented assembly, as the 
assembly tools cannot determine the correct assembly of these 
regions and simply stop extending the contigs at the border 
of the repeats4. To resolve the assembly of repeats, reads 
need to be long enough to also include the unique sequences 
flanking the repeats. It can therefore be a good idea to order 
data from a long-read technology, if you know that you are 
working with a genome with a high content in repeats.
Heterozygosity
Assembly programs in general try to collapse allelic differ-
ences into one consensus sequence, so that the final assembly 
that is reported is haploid. If the genome is highly heterozygous, 
sequence reads from homologous alleles can be too different to be 
assembled together and these alleles will then be assem-
bled separately. This means that heterozygous regions might 
be reported twice for diploid organisms, while less variable 
regions will only be reported once, or that the assembly simply 
fails at these variable regions5. Highly heterozygous genomes 
can lead to more fragmented assemblies, or create doubt about 
the homology of the contigs. Large population sizes tend to lead 
to high heterozygosity levels. For instance, marine organisms 
often have high heterozygosity levels and are often problematic 
to assemble. It is recommended to sequence inbred individuals, 
if possible.
Ploidy level
If possible, it is better to sequence haploid tissues (true for 
bacteria and many fungi) since, this will essentially remove 
problems caused by heterozygosity. Diploid tissues, which 
will be the case for most animals and plants, is fine and usu-
ally manageable, while tetraploidy and above has the potential 
to greatly increase the number of present alleles, which likely 
will result in a more fragmented assembly (see heterozygosity 
above). Diploid-aware assemblers using long reads can help, 
but keep in mind that correct assembly of diploid genomes 
might require higher coverage.
GC-content
Extremely low or extremely high GC-content in a genomic 
region is known to cause a problem for Illumina sequencing, 
resulting in low or no coverage in those regions6. This can be 
compensated by an increased coverage, or the use of a 
sequencing technology that does not exhibit that bias (i.e., Pac-
Bio or Nanopore). If you are working with an organism with a 
known low or high GC-content, we would recommend using 
a sequencing technology that does not exhibit any bias in this 
regard.
2. Extract high quality DNA
Intrinsic properties of the genome are not the only considera-
tion before sequencing. There are also other aspects that need 
careful planning. The extraction of high quality DNA is one 
such aspect that is of utmost importance. We discuss DNA 
extraction in some detail below, but also end this section 
with a short list of other pre-assembly considerations important 
to keep in mind when starting an assembly project.
DNA quality requirements for de novo sequencing
Few researchers are aware of the fact that to get a good 
reference genome one must start with good quality material. 
It must be immediately pointed out that PCR-quality DNA 
and NGS-quality DNA are two completely different things7.
In general, we recommend using long-read technologies 
(see also Section 3 below) when carrying out genome assem-
bly. For these technologies, it is crucial to use best quality High 
Molecular Weight (HMW) DNA, which is obtained mainly 
from fresh material. The lack of a good starting material will 
limit the choice of sequencing technology and will affect the 
quality of obtained data.
The most important DNA quality parameters for NGS are 
chemical purity and structural integrity of the sample.
Chemical purity
DNA extracts often contain carry-over contaminants 
originating either from the starting material or from the DNA 
extraction procedure itself. Examples of sample-related contami-
nants are polysaccharides, proteoglycans, proteins, secondary 
metabolites, polyphenols, humic acids, pigments, etc. For instance, 
fungal, plant and bacterial samples can contain high levels of 
polysaccharides, plants are notorious for their polyphenols, and 
insect samples are usually contaminated by polysaccharides, pro-
teins and pigments, and so on. All these contaminants can impair 
the efficacy of library preparation in any technology, but this is 
especially true for Illumina Mate Pair libraries and PCR-free 
libraries (both PacBio and ONT). For conventional 
short-read technology sequencing where a PCR step is involved 
in the library prep, this hurdle is partly overcome by the 
amplification step during the library construction. However, it 
can happen that the library complexity of a contaminated sample 
can be reduced due to lower efficacy of the reaction. It 
is widely known in the PacBio community that samples rich 
in contaminants can fail or underperform in the sequencing 
process, since there is no PCR step in the library preparation 
and sequencing workflow.
The way to address the contamination issue is to use 
an appropriate DNA extraction protocol taking into account the 
expected type of contaminants present in the sample (native 
contaminants). CTAB (cetyl trimethylammonium bromide) 
extraction is highly recommended for DNA extraction from 
fungi, mollusks and plants; at a certain salt concentration CTAB 
helps to differentially extract DNA from solutions containing 
high level of polysaccharides8 . For protein rich tissues, adding 
beta-mercaptoethanol (disrupting disulphide bonds in protein 
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molecules) and optimization of Proteinase K treatment is 
recommended9. For  plants, it is important to always use a com-
bination of beta-mercaptoethanol (to prevent polyphenols from 
oxidizing and binding to DNA) and PVPP (polyvinyl polypyrro-
lidone; to absorb polyphenols and other aromatic compounds)10. 
For animal and human samples, it is advised to use tissues with 
low fat and connective tissue content.
Structural integrity of DNA
Aside from native contaminants, phenol, ethanol and salts can 
be introduced during the DNA extraction procedure. Incom-
plete removal of phenol, or not using fresh phenol will harm 
DNA (e.g. introducing nicks making the nucleic acid more 
fragile); it can also impair enzymes used in downstream 
procedures, as can incompletely removed ethanol. High salt 
concentrations (e.g. EDTA carry-over) can potentially lower 
efficacy of any downstream enzymatic reactions.
A second important issue is the DNA structural integrity, 
which is especially important for long-read sequencing tech-
nologies. DNA can become fragile due to nicking introduced 
during DNA extraction, or using storage buffer with inappro-
priate pH. Prolonged DNA storage in water and above -20°C is 
not recommended; it increases the DNA degradation risk due to 
hydrolysis. High molecular weight DNA is fragile; therefore 
using gentle handling (vortexing at minimal speed, pipetting 
with wide-bore pipette tips, transportation in a solid frozen 
stage) is advised. It is also advisable to keep the number of 
freeze-thaw cycles to a minimum, since ice-crystals can mechani-
cally damage the DNA. For the same reason, one  should avoid 
DNA extraction protocols involving harsh bead-beating treatment 
during tissue homogenization.
It must be also pointed out that RNA contamination of 
DNA samples must be avoided. Most NGS DNA library preps 
can only efficiently utilize double-stranded DNA. Having RNA 
contamination in the sample will overestimate the library nucleic 
acid molecules concentration. That is especially true for PacBio 
and 10X Chromium libraries.
To summarize, it is always worth investing time in 
getting a high quality DNA prep – it can potentially save lots of 
time and money that would otherwise be spent on sequencing 
troubleshooting, ordering more data, or, if ordering more data 
is not possible, trying to assemble a genome with a coverage 
that is lower than expected.
Other considerations
•     Pooling of individuals – For some organisms it can be 
difficult to extract a sufficient amount of DNA, and in 
these cases it might be tempting to pool several individuals 
before extraction. Note that this will increase the genetic 
variability of the extraction, and can lead to a more 
fragmented assembly, just like high levels of heterozygosity 
would. In general pooling should be avoided, but if it is 
done, using closely related and/or inbred individuals is 
recommended.
•     Whole Genome Amplification (WGA) – In cases where 
perhaps only a few cells are available, the genomic DNA 
needs to be amplified to be sequenced. This will often 
result in uneven coverage, and in the case of amplification 
methods relying on multiple strand displacement, 
artificial so called chimeric sequences consisting of fused 
unrelated sequences can be created11. Be aware that this 
can cause mis-assemblies. If possible, use an assembly 
tool designed to work with amplified DNA, for example 
SPAdes12.
•     Presence of other organisms – Contamination is always 
a risk when working with DNA. For genome assembly, 
contamination can be introduced in the lab at the DNA 
extraction stage, or other organisms can be present in 
the tissue used, e.g. contaminants and/or symbionts. 
Care should be taken to make sure that the DNA of 
other organisms does not occur in higher concentrations 
than the DNA of interest, as many reads will then be 
from the contaminant rather than the genome of the studied 
organism. Small amounts of contamination are rarely 
a problem as these reads can be filtered out at the read 
quality control step or after assembly, unless the 
contaminants are highly similar to the studied organism.
•     Organelle DNA - Some tissues are so rich in 
mitochondria or chloroplasts that the organelle DNA 
occurs in higher concentrations than the nuclear DNA. This 
can lead to lower coverage of the nuclear genome in your 
sequences. If you have a choice, choose a tissue with a 
higher ratio of nuclear over organelle DNA.
3. Choose an appropriate sequencing technology
The choice of which sequencing technology to use is an 
important one (Figure 1). It will influence the cost and success 
of the assembly process to a large degree. In this section, we will 
discuss the currently available and most commonly used options, 
and also some supporting technologies. It is worth mentioning 
that assembly programs are often very specific in what type of 
data they accept, and might not be able to analyze reads from dif-
ferent sequencing technologies together. You should decide how 
to analyze your sequence data before you order it, to decrease 
the risk of needing to order, and wait for, more DNA/RNA 
material just to be able to perform your analyses.
First generation sequencing (FGS)
These technologies started with the Sanger sequencing 
method developed by Frederick Sanger and colleagues in 1977. 
The method is based on selective incorporation of chain- 
terminating dideoxynucleotides by DNA polymerase during 
in vitro DNA replication. FGS technologies were the most 
widely used for approximately 30 years13,14.
During the last decade, the Sanger method has been replaced by 
High-Throughput Sequencing platforms (HTS), in particular 
by Second-Generation Sequencing (SGS), which is much less 
expensive. However, the Sanger method remains widely 
used in smaller-scale projects and for closing gaps between 
contigs generated by HTS platforms.
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Figure 1. Timeline and comparison of different sequencing technologies. The data is based on the throughput metrics for the different 
platforms since their first instrument version came out. The figure visualises the results by plotting throughput in raw bases versus read length. 
Data released under CC BY 4.0 International license. doi 10.6084/m9.figshare.100940.
SGS and Third-Generation Sequencing
The SGS have dominated the market, thanks to their 
ability to produce enormous volumes of data cheaply. 
Examples are the Illumina or Ion Torrent sequencers. Many 
remarkable projects like the 1000 Genomes Project15 and the 
Human Microbiome Project16 have been finished thanks to SGS 
technologies. However, some genes and important regions of 
interest are often not assembled correctly, mainly due to the pres-
ences of repeat elements in the sequences17. A promising solution 
is Third-Generation-Sequencing (TGS) based on long reads18. 
TGS technologies have been used for the reconstruction of 
highly contiguous regions in eukaryotic genomes19,20 and de novo 
microbial genomes with high precision21. In terms of resequenc-
ing, the TSG technology has generated detailed maps of the 
structural variations in multiple species and has covered many of 
the gaps in the human reference genome22,23.
Currently, the two most important third-generation DNA 
sequencing technologies are Pacific Biosciences (PacBio) Single 
Molecule Real Time (SMRT) and Oxford Nanopore Technology 
(ONT)24. These technologies can produce long reads averaging 
between 10,000 to 15,000bp, with some reads exceeding 
100,000bp.
However, these long reads exhibit per sequence error rates up 
to 10% to 15%, requiring a preliminary stage of correction 
before or after the assembly process. In fact, long read 
assembly has caused a paradigm shift in whole-genome assembly 
in terms of algorithms, software pipelines and supporting steps25.
Supporting technologies
There are also supporting technologies, most of which 
are used to improve the contiguity of already existing genome 
assemblies. These include optical mapping methods (e.g., Bio-
Nano), linked-read technologies (e.g., 10X Genomics Chromium 
system), or the genome folding-based approach of HiC26. In a 
rapidly changing field, it is difficult to recommend one of these 
technologies over the others. We advise researchers interested 
in assembling large genomes to read up on the current status 
of these methods when ordering sequence data, and remember 
to budget for them. For researchers interested in large-scale 
structural changes, the improvements of contiguity provided by 
these methods will be of extra interest.
Long reads definitely have an advantage over shorter reads 
when used in genome assembly as they deal with repeats much 
better. In practice, this often leads to less fragmented assemblies, 
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which is what most researchers are aiming for. The problems 
with third generation technologies are a higher price, a lack of 
availability in some countries, and sometimes higher require-
ments in terms of DNA amount and quality. Unless these 
complicating factors prevents the use of third generation long read 
technologies in your research project, we strongly recommend 
them over short read technologies. That being said, a 
combination of both might be even better, as the shorter reads 
have a different error profile and can be used to correct the 
longer ones27 (see Section 5).
4. Estimate the necessary computational resources
To succeed in a genome assembly and annotation project 
you need to have sufficient compute resources. The resource 
demands are different between assembly and annotation, 
and different tools also have very different requirements, but 
some generalities can be observed (for examples, see Table 1).
For genome assembly, running times and memory requirements 
will increase with the amount of data. As more data is needed 
for large genomes, there is thus also a correlation between 
genome size and running time/memory requirements. Only a 
small subset of available assembly programs can distribute the 
assembly into several processes and run them in parallel on sev-
eral compute nodes. Tools that cannot do this tend to require 
a lot of memory on a single node, while programs that can 
split the process need less memory in each individual node, 
but do on the other work most efficiently when several nodes 
are available. It is therefore important to select the proper 
assembly tools early in a project, and make sure that there are 
enough available compute resources of the right type to run these 
tools.
Annotation has a different profile when it comes to computer 
resource use compared to assembly. When external data such 
as RNA-seq or protein sequences are used (something that is 
strongly recommended), mapping these sequences to the 
genome is a major part of the annotation process. Mapping 
is computationally intense, and it is highly preferable to use 
annotation tools that can run on several nodes in parallel.
Regarding storage, usually no extra consideration needs to 
be taken for assembly or annotation projects compared to other 
NGS projects. Intermediate files are often much larger than 
the final results, but can often be safely deleted once the run is 
finished.
5. Assemble your genome
In general, irrespective of the sequencing technology you 
choose, you would follow the same workflow (Figure 2). In the 
quality control (QC) stage the sequence reads are examined 
for overall quality and presence of adapters. Presence of con-
taminants can also be examined. In the assembly stage, several 
assemblers are often tried in parallel and the results are then com-
pared in the assembly validation step, where mis-assemblies also 
can be identified and corrected. Often, assemblers are rerun with 
new parameters based on the results of the assembly validation. 
The aim is usually to create a genome assembly with the longest 
possible assembled sequences (least fragmented assembly) with 
the smallest number of mis-assemblies.
Quality control of reads and the actual genome assembly 
are different for the Illumina technology compared with long read 
technologies. These technologies will be discussed separately 
hereafter. We end this section with a discussion about assembly 
validation, which is similar for all technologies.
Illumina Genome assembly
The most common approach to perform genome assemblies is 
de novo assembly, where the genome is reconstructed exclu-
sively from the information of overlapping reads. For 
prokaryotes, it is also common to assemble with a reference 
genome, e.g., when complete strain collections are sequenced. 
The reference sequence can either be used as a template to 1) 
guide the mapping of reads, or 2) reorder the de novo assembled 
contigs.
In general, Illumina sequencing technology produces 
large amounts of high quality short sequence reads. The adapter 
and multiplex index sequences are screened for and removed 
after the base calling on the sequencing machine. However, it 
is highly recommended to assess the raw sequence data quality 
prior to assembly. Poor quality reads, ambiguous base calling, 
contamination, biases in the data and even technical issues 
on the sequencing chip, are some, but not all, possible techni-
cal errors that can be detected early and corrected28. Also, if the 
sequencing libraries contain very short fragments, it is likely 
that the sequencing reaction will continue past the DNA insert 
and into the adapter in the 3’ end, a process known as adapter 
read-through, which may escape the adapter screening step 
on the sequencing machine29.
Assessing the quality of Illumina short reads
Assessing the quality of the sequence data is important, 
as it may affect downstream applications and potentially lead 
to erroneous conclusions. Base calling accuracy measures 
the probability that a given base is called incorrectly, and is 
commonly measured by the Phred quality score (Q score). Sev-
eral tools are available for the quality assessment. FastQC30 
is a commonly used tool that can be run both from the command 
line or through an interactive graphical user interface (GUI). 
It produces plots and statistics showing, among others, the 
average and range of the sequence quality values across the 
reads, over-represented sequences and k-mers which in total 
can help the user interpret data quality. k-mers represent 
all subsequences of length k in a sequence read. Most methods 
for assembling or mapping reads are based on the use of k-mers. 
More in depth analysis of k-mers can also be performed, for 
example using KAT31 to identify error levels, biases and 
contamination, and this also comes highly recommended.
Pre-processing of raw data
After having investigated the sequence data quality, 
informed decisions on downstream operations can be made. 
We would in general recommend that adapters are removed, 
although there are also assemblers that prefer working with the 
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Figure 2. General steps in a genome assembly workflow. Input and output data are indicated for each step.
raw data, including potential adapter sequences. It is highly rec-
ommended that the user studies the assembler documentation to 
determine whether the program requires quality-trimmed data or 
not. If trimming is required by the assembler, it would be 
sensible to omit poor quality data from further analysis by 
trimming low quality read ends and filtering of low quality reads. 
A variety of tools are available, such as PRINSEQ32, which 
offers a standalone command-line version, a version with a GUI 
and an online web based service, and Trimmomatic33.
Illumina machines produce a wide range of read numbers, from 
10 millions up to 20 billions (NovaSeq). Reducing the sequence 
coverage by subsampling for deeply sequenced genomes 
is recommended, as de Brujin assemblers work best around 
60-80x coverage34. High coverage in a particular genome loca-
tion will increase the probability that this location is seen as 
a sequencing error or sequencing errors can propagate and 
start to look like true sequence. BBnorm35, a member of the 
BBTools package, is a common kmer-based normalisation 
tool that can normalise highly covered regions to the expected 
coverage.
Short reads genome assembly
For the de novo assembly of short reads, the most commonly 
used algorithms are based on de Bruijn graphs, although 
other algorithms such as Overlap Layout Consensus (OLC)36 are 
still being used. One of the advantages of de Bruijn graph over 
OLC is that it consumes less computational time and memory. 
Depending on the complexity of the genome to be 
assembled such as size, repeat-content, polyploidy, a proper 
tool should be selected. Some assembly tools, such as SPAdes12, 
work best with smaller amounts of data and are thus well 
adapted for bacterial projects, while others handle large amounts 
of data well and can be used for any type of project. These include 
allpaths-LG37 and Masurca38. Note that with large amounts 
of data, available RAM will be a limiting factor.
The characteristics of the genomes being assembled 
have a greater impact on the results than the choice of the algo-
rithm. Haploid genomes with no sequence repeats will be 
much easier to reconstruct than genomes of polyploids or 
genomes with many sequence repeats e.g. many plants species. 
The GAGE-B study39 showed that assembly software perform-
ing well on one organism, performed poorly on another organism. 
Hence, it is wise to test several approaches; different soft-
ware, assembly with or without pre-processing of the sequence 
data, and also with different parameter settings. Another 
approach that will have impact on the assembly is the use of 
mate pair sequencing. This enables the generation of long-insert 
paired-end DNA libraries with fragments up to 15 kb, and can 
be particularly useful in de novo sequencing. The large inserts 
can span across regions problematic to the assembler such 
as repetitive elements, and anchor the paired reads in unique parts 
of the DNA, and reduce the number of contigs and scaffolds. 
Despite the enormous development in this field, it is still 
challenging to assemble large genomes from short reads. Fur-
ther improvements, both in the assembly technology, but also in 
increasing read length and in fragment size is needed for more 
accurate reconstruction of genomes.
Long read genome assembly
TGS developed by Pacific Biosciences or Oxford Nanopore 
is able to produce long reads with average fragment lengths 
of over 10,000 base-pairs that can be advantageously used 
to improve the genome assembly40. In fact, long reads can 
span stretches of repetitive regions and thus produce a more 
contiguous reconstruction of the genome. However, raw long 
reads have a high rate of sequencing error (5–20%). As a result, 
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some long read assemblers opt to correct these errors prior to 
assembly.
There are two main families of assemblers based on long reads:
•    Long Reads Only assembler (LRO)
•    Short and Long Reads combined assembler (SLR)
In general, LRO assemblers are based on the OLC algorithm. 
First, this algorithm produces alignments between long reads. 
Then it calculates the best overlap graph, and finally it generates 
the consensus sequence of the contigs from the graph. LRO 
assemblers require more sequencing coverage (minimum ~50X) 
from the long reads dataset than SLR assemblers. Schemati-
cally, SLR assemblers instead generate a de Bruijn graph pre- 
assembly using short reads, then the long reads are used to 
improve the pre-assembly by closing gaps, ordering contigs, and 
resolving repetitive regions. It is worth noting that some long 
reads assemblers require corrected long reads as input. Software 
to correct long reads are based on two strategies. The first strat-
egy consists of aligning long reads against themselves. The second 
one uses short reads to correct long reads.
A document with guideline practices for long-reads genome 
assemblies is available41. This document shows the perform-
ance of long read assembly benchmarked against 4 reference 
genomes: Acinetobacter DP1, Escherichia coli K12 MG1655, 
Saccharomyces cerevisae W303 and Caenorhabditis elegans 
(sequenced in different TGS platforms and under different con-
ditions). Among the 11 tools that have been evaluated, 8 use 
only long reads as input data, while the 3 others can assemble 
genome using a mix of long and short reads. The tests show that 
it is strongly recommended to use a long read correction software 
before the assembly42.
Assembly polishing
Although an error correction step may have been part of 
the assembler pipeline, errors can still be present in the assem-
bly, particularly in long read assemblies. Polishing draft assem-
blies with either short or long reads can help to improve local 
base accuracy in particular correcting base calls and small inser-
tion-deletion errors, and also resolve some mis-assemblies 
caused by poor reads alignment during the assembly43.
Scaffolding and gap filling
In scaffolding, assembled contigs are stitched together based 
on information from paired short reads. The unknown sequence 
between the contigs will be filled with Ns. If matching 
reads are instead used to join contigs together, for example long 
reads, actual sequence will fill in the gaps, and this is referred 
to as gap filling. In the case of an existing scaffolded assembly, 
long reads can also be used to replace the N-regions. Note that 
misassemblies in an existing assembly need to be broken 
prior to scaffolding in order to join the correct contigs together. 
Scaffolding and gap filling can be performed with low coverage44.
Determining whether the assembly is ready for annotation
Determining if the assembly is ready for annotation is a key step 
towards successful genome annotation. Errors in assemblies 
occur for many reasons. Genomic regions can be incorrectly 
discarded as being fallacies or repeats. Others can be spliced 
together in the wrong places or in the wrong orientation. 
Unfortunately, there are few ways to distinguish what is real, 
what is missing, and what is an experimental artefact. There are, 
however, some statistics that often are used when choosing 
between assemblies, and some ways of identifying and 
removing potential problems.
N50 is often used as a standard metric to evaluate an 
assembly45. N50 is the length of the smallest contig, after they 
have been ranked from longest to smallest, such that the sum of 
contig lengths up to it covers 50% of the total size of all contigs. 
It is thus a measure of contiguity, with higher numbers indicating 
lower levels of fragmentation. It is important to note that N50 is 
not a measure of correctness. So-called aggressive assemblers 
may produce longer contigs and scaffolds than conservative 
assemblers, but are also more likely to join regions in the 
wrong order and orientation. We recommend to compare the 
output from different assemblers (and of trimmed/filtered 
data). Assembly evaluation tools, such as Quast46, compare 
the metrics between assemblies, and allow the user to make 
educated choices to further improve and select the best assem-
bly. If a reference sequence is available, Quast can also describe 
mis-assemblies and structural variations relative to the refer-
ence. If paired Illumina data is available, tools such as Reapr47 or 
FRCBam48 can be used to evaluate assemblies and to iden-
tify which assembly has the least amount of misassemblies. 
If other organisms were present in the reads (contaminants or 
symbionts) and have been assembled together with the other 
reads, these contigs can be identified using for example 
Blobtools49 and removed, if necessary. To determine how 
many protein coding genes have been assembled, BUSCO50 is 
very useful. This tool looks for genes that should be present 
in a genome of the investigated taxonomic lineage type, and 
reports the number of complete and fragmented genes found. 
Choosing the assembly with the highest percentage of 
complete genes could be given greater importance if the purpose 
of the genome project is to investigate protein coding genes.
Knowing when to stop assembly and moving into annotation 
is one of the most difficult decisions to take in genome assem-
bly projects. It is always possible to try one more tool or 
one more setting, and this wish of wanting to improve the 
assembly just a little bit more can delay these types of projects 
substantially. It is best to have a goal in mind before starting 
assembly, and to stop when that goal has been reached. 
If you feel that you can answer the questions you had before 
starting, then the assembly is good enough for your purposes 
and it is probably time to move into annotation. It is always 
possible to release a new and improved version of the genome 
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later. Be aware that any changes to a genome assembly will 
most likely necessitate annotation to be re-started from scratch, 
and you should therefore be sure to “freeze” the assembly 
completely before starting annotation.
6. Do not neglect to annotate Transposable Elements
The genome annotation stage starts with repeat identification 
and masking.
There are two different types of repeat sequences: 
‘low-complexity’ sequences (such as homopolymeric runs of 
nucleotides) and transposable elements. Transposable Ele-
ments (TEs) are key contributors to genome structure of almost 
all eukaryotic genomes (animals, plants, fungi). Their abun-
dance, up to 90% of some genomes such as wheat51, is usually 
correlated with genome size and organization. TEs ability 
to move and to accumulate in genomes, make them a major 
players of genome structure, plasticity, genetic variations 
and evolution. Interestingly, they can affect gene expression, 
structure and function when their insertion occurs in the vicinity 
of genes52 and sometimes through epigenetic mechanisms53.
TEs are classified in two classes including subclasses, 
orders and superfamilies according to mechanistic and enzy-
matic criteria. These two classes are based on their mechanism 
of transposition using a copy-and-paste (Class I) or cut-and- 
paste mechanisms (Class II) through RNA or DNA intermediates 
respectively54.
TE annotation is nowadays considered as a major task 
in genome projects and should be undertaken before any 
other genome annotation task such as gene prediction. 
Consequently, there has been a growing interest in develop-
ing new methods allowing an efficient computational detection, 
annotation, and analysis of these TEs, in particular when they 
are nested and degenerated. Many software have been devel-
oped to detect and annotate TEs55. One of the best known is 
RepeatMasker, which harnesses nhmmer, cross_match, ABBlast/
WUBlast, RMBlast and Decypher as search engines and uses 
curated libraries of repeats, currently supporting Dfam (profile 
HMM library) and Repbase56,57.
Another important tool is the REPET package, one of the 
most used tools for large eukaryotic genomes with more 
than 50 genomes analyzed in the framework of international 
consortia. The REPET package is a suite of pipelines and tools 
designed to tackle biological issues at the genomic scale.
REPET consists of two main pipelines: TEdenovo and 
TEannot. First, TEdenovo efficiently detects classified TEs 
(TEdenovo pipeline), then TEannot annotates TEs, including 
nested and degenerated copies58.
Depending on the complexity and number of detected TEs, 
it might be possible that additional rounds of TEs identification 
and removal are needed once the initial gene set has been pro-
duced. It is a common practice to analyze the functional annotation 
of the initial gene set to detect those genes which are 
primarily annotated with terms associated to TEs activity. Those 
genes can be safely removed if they do not have homologous 
sequences in relative species and/or their homologous sequences 
have been annotated as TEs related59.
7. Annotate genes with high quality experimental 
evidence
7.1. Structural annotation – where are the genes and what 
do they look like?
A raw genomic sequence is to most biologists of no 
great value as such. Genome annotation consists of attach-
ing biological meaningful information to genome sequences 
by analyzing their sequence structure and composition as well 
as to consider what we know from closely related species, which 
can be used as reference. While genome annotation involves 
characterizing a plethora of biologically significant ele-
ments in a genomic sequence, most of the attention is spent on 
the correct identification of protein coding genes. This is 
not because the other types of genetic elements are of 
lesser importance, far from actually, but mainly because the 
approaches to characterize them are either fairly straightfor-
ward (eg. INFERNAL60 and tRNAscan-se61 for non-coding RNA 
detection) or are the focus of more specialized analyses 
(eg. transcription factor binding sites).
The process of correctly determining the location and 
structure of the protein coding genes in a genome, “gene pre-
diction”, is fairly well understood with many successful 
algorithms being developed over the past decades. In general, there 
are three main approaches to predict genes in a genome: intrin-
sic (or ab-initio), extrinsic and the combiners. Where the intrin-
sic approach focuses solely on information that can be extracted 
from the genomic sequence itself such as coding potential and 
splice site prediction, the extrinsic way uses similarity to other 
sequence types (e.g. transcripts and/or polypeptides) as informa-
tion. There are inherent advantages and disadvantages to each of 
those.
The intrinsic approach is labor intensive as statistical models 
need to be built and software needs to be trained and optimized. 
Of prime importance for this approach is a good training set, 
i.e. a set of structurally well annotated genes used to build mod-
els and to train gene prediction software. As each genome is 
different, these models and software must be specific to each 
genome and thus need to be rebuilt and retrained for each 
new species. This is, however, also the big advantage of this 
approach, as it is capable of predicting fast evolving and species 
specific genes.
The extrinsic way, on the other hand, is much more univer-
sally applicable. A vast number of polypeptide sequences 
are already described and available in databases (eg. NCBI non-
redundant protein, RefSeq, UniProt), which creates a wealth of 
information to be exploited in the gene prediction process. Tran-
script information, be it Sanger sequenced ESTs, RNA-Seq or 
even long read sequenced transcripts, plays an even bigger role 
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Figure 3. Simplified Illustration of a structural genome annotation using Combiners. On the left, the diagram shows a typical assembly 
process. At the end of the process, scaffolds or chromosomes ready to be annotated are obtained. These scaffolds are then annotated using 
two different methods. The first method is called ab-initio and requires a known set of training genes. Once the ab initio tool has been trained 
it can be used to predict other similarly structured genes. The second similarity-based approach relies on experimental evidence such as 
CDSs, ESTs, or RNA-seq to build gene models. Combiners (such as Maker or Eugene) can then incorporate all of these results, eliminate 
incongruences, and present gene models best supported by all methods.
in this approach. High quality protein sequences of other spe-
cies provide good indication on the presence and location of 
genes and can be very useful to accurately predict the cor-
rect gene structure. Indeed, as polypeptide sequences often are 
more conserved than the underlying nucleotide sequences, they 
can still be aligned even from distantly related species. 
Although they are very useful to determine the presence of 
gene loci, they do not always provide accurate information 
on the exact structure of a gene. Transcripts on the other hand 
provide very accurate information for the correct prediction of 
the genes’ structure but are much less comprehensive and to 
some extent are noisier. Transcript information will 
not be available for all genes and sometime introns can still 
be present due to incomplete mRNA processing. Nonetheless, 
accurate alignment of the extrinsic data is key here: transcripts 
need to be splice-aligned (taking the exon-intron structure of 
eukaryotic genes into account) and protein sequences need to be 
compared to the six translation-frames of the nucleotide 
sequences. Moreover, it is a matter of thresholds: too stringent 
and less conserved genes will be missed, while too lenient will 
result in less specific information and introduce more false 
positives. These thresholds will depend on your objectives. 
A recommendation is to use lenient parameters in order to mini-
mize the number of false negatives, as it is more difficult to 
create a new gene than to change the status of a false posi-
tive to obsolete. Then according to different confidence scores 
(e.g. coding potential, GO Evidence Codes), you can filter the 
gene set in order to provide, for instance, a high confidence gene 
set to train ab initio software, or a high confidence gene set 
to submit to a suitable repository and keep the full set for manual 
curation.
The combiners are probably the most popular and widely 
used gene prediction approach. They integrate the best of both 
worlds: they have an ab initio part that is then often complemented 
with extrinsic information (Figure 3). Especially, nowadays, with 
the advances of sequencing technologies, these approaches are 
increasingly used, reflecting the growing number of new tools 
and software trying to integrate RNA-Seq, protein or even intrin-
sic information. However, not all these combiners are the same. 
While some simply aim to pick the most appropriate model 
or build the consensus out of the provided input data (where an 
ab initio prediction tool might be one of them) for a given 
locus, others have a more integrated approach in which the intrin-
sic prediction can be modified by the given extrinsic data. The 
advantage of the latter is that they allow one type of 
information to overrule the other if this results in an overall 
more consistent prediction.
Apart from the choice of which tool to use, the choice 
of which data to integrate also has an influence on the final result. 
This is especially the case for the use of protein information. 
Error propagation is a real danger. Therefore, curated data-
sets, are preferred over the more general but less clean ones 
because it is vital that the provided information be as reliable as 
possible. The use of transcript information is less prone to error 
propagation although it is of importance that one realises what 
kind of data is being used. Short read RNA-Seq data is easily 
generated and is often an inherent part of a genome project. A 
downside is the short length of the reads. It will give accurate 
information on the location and existence of the exons but it 
will sometimes be more difficult to know how these exons are 
combined into a single gene structure. Therefore, it is becoming 
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Figure 4. Functional Annotation Pipelines. This schema is showing a typical functional annotation pipeline, in which functional roles are 
assigned to coding sequences (CDSs) inferred in the gene prediction process. The process implements three parallel routes for the definition 
of functions. The first refers to proteins domains and motifs, the second for orthology search and finally the third is applied to homology 
search. At the end, the output from the three different sources is put together for more valuable predictions.
common to complement the short read transcript data 
with long read transcript information. Those will often contain 
the full set of exons into a single read and will as such provide 
unambiguous information on the complete gene structure and 
even alternative transcripts.
When performing genome annotation, choices have to 
be made, not only what tools to use but equally important 
what kind of data to use. It is clear that the choice should go 
towards the more reliable but unfortunately sometimes less com-
prehensive data sources as the use of lower quality information 
will inevitably lead to an inferior gene prediction result.
7.2. Functional annotation
The ultimate goal of the functional annotation process 
(Figure 4) is to assign biologically relevant information to pre-
dicted polypeptides, and to the features they derive from (e.g. 
gene, mRNA). This process is especially relevant nowadays in 
the context of the NGS era due to the capacity of sequencing, 
assembling, and annotating full genomes in short periods of 
time, e.g. less than a month. Functional elements could range 
from putative name and/or symbols for protein-coding genes, 
e.g. ADH to its putative biological function, e.g. alcohol dehy-
drogenase, associated gene ontology terms, e.g. GO:0004022, 
functional sites, e.g. METAL 47 47 Zinc 1, and domains, 
e.g. IPR002328, among other features. The function of predicted 
proteins can be computationally inferred based on the similar-
ity between the sequence of interest and other sequences in dif-
ferent public repositories, e.g. BLASTP against Uniprot. Caution 
should be taken when assigning results merely based on 
sequence similarity as two evolutionary independent sequences 
which share some common domains could be considered 
homologs62. Thus, whenever possible, it is better to use ortholo-
gous sequences for annotation purposes rather than simply 
similar sequences63. With the growing number of sequences in 
those public repositories, it is possible to perform various searches 
and combine obtained results into a consensus annotation. 
The accurate assignment of the functional elements is a complex 
process, and the best annotation will involve manual curation.
There are two main outcomes of the functional annotation 
process. The first is the assignment of functional elements to 
genes. Downstream analysis of these elements allow further 
understanding of specific genome properties, e.g. metabolic path-
ways, and similarities compared with closely related species. 
The second result of the functional annotation is the additional 
quality check for the predicted gene set. It is possible to identify 
problematic and/or suspicious genes by the presence of spe-
cific domains, suspicious orthology assignment and/or absence 
of other functional elements, e.g. functional completeness. These 
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problematic genes can include those belonging to another spe-
cies due to contamination, those detected as TEs, non-functional 
and/or artefactual genes annotated by error.
There are a number of tools available for functional 
annotation that allow users to obtain annotations for their gene 
set of interest via public databases in a high-throughput manner. 
These tools often start by sequence similarity search using tools 
like BLAST, HMMER or LAST against either non-redundant 
sequences database from NCBI GenBank and/or UniProt ref-
erence clusters (UniRef). After the initial homology search, 
candidate sequences can be assigned to one or more orthol-
ogy groups using either best-reciprocal or tree-based methods63. 
Alternatively, users can make use of machine learning meth-
ods, such as Hidden Markov Models (HMM) or neural networks 
to predict particular patterns from a given input gene set. The 
majority of these tools are freely available for the academic 
users, working under Linux OS and are often part of large-scale 
annotation pipelines.
For those users who do not want to run individual tools 
and combine results, there are a few available workflows 
that provide the entire annotation process. These pipelines 
can either include installation of the required tools and corre-
sponding databases, or users are required to make this installation 
on their own and the pipeline just provides a framework for the 
analysis.
8. Use well-established output formats and submit 
your data to suitable repositories
Data formats
The output of a genome annotation pipeline is almost 
always in GFF format. The information captured includes the 
structure and often the function of features of the genome, but 
usually not the actual sequence. Together with the Fasta file that 
was used in the annotation process, the sequence of these fea-
tures can however easily be extracted. Other output formats are 
GTF, BED, Genbank, and EMBL, of which the last two 
include both sequence and annotation and are often used when 
submitting annotation results to sequence repositories. Some 
of these formats use controlled vocabularies and ontologies to 
guarantee interoperability between analysis and visualisation 
tools. We highly recommended the adoption of Fasta and GFF3 
output formats. Both formats are compatible with the Genetic 
Model Organism Database (GMOD), a powerful suite of 
tools used for genome annotation, visualisation, and redistribu-
tion of genome data. By adhering to commonly used formats, 
you are making your results more useful to other researchers.
Data submission
To improve the availability and findability of results 
from genome annotation projects, the annotated sequences have 
to be submitted to databases, such as Genbank at the National 
Center for Biotechnology Information (NCBI)64 or the European 
Nucleotide Archive (ENA)65. In these archives, the information 
relating to experimental workflows are captured and displayed. 
A typical workflow includes: 1) the isolation and preparation 
of material for sequencing, 2) a run of a sequencing machine 
in which sequencing data are produced, and 3) a subsequent 
bioinformatic analysis pipeline. ENA records this information 
in a data model that covers input information (sample, experi-
mental setup, machine configuration), output machine data 
(sequence traces, reads and quality scores) and interpreted 
information (assembly, mapping, functional annotation).
There are also a growing number of theme-based genome data-
bases. Human genome sequence projects are recommended to 
use the European Genome-phenome Archive (EGA)66. EGA 
is a service for permanently archiving and sharing data resulting 
from biomedical research projects, and all types of personally 
identifiable genetic and phenotypic can be included. This service 
provides the necessary security to control access and maintain 
the confidentiality of patient data, while providing access to 
researchers and authorized physicians to view the data. The 
data was collected from individuals whose consent agreements 
authorize the disclosure of data only for specific investigations.
9. Ensure your methods are computationally 
repeatable and reproducible
Reproducibility and repeatability have been reported as 
a major scientific issue when it comes to large scale data 
analysis67. For genomics to fulfil its complete scientific and social 
potential, in silico analysis must be both repeatable, reproduc-
ible and traceable. Repeatability refers to the re-computation 
of an existing result with the original data and the original soft-
ware. For instance, the authors report numerical instability arising 
from a mere change of Linux platforms, even when using 
exactly the same version of the genomic analysis tools.
Fortunately, solutions exist and along with their report 
of numerical instability, the authors did show that repeat-
ability could be achieved through the efficient combination of 
containers technology and workflow tools. Containers can be 
described as a new generation of lightweight virtual machines 
whose deployment has limited impact on performances. 
Container methods, such as Docker and Singularity, make it pos-
sible to compile and deploy a software in a given environment, 
and to later re-deploy that same software in the same original 
environment while being hosted on a different host environment. 
Once encapsulated this way, analysis pipelines were shown to 
become entirely repeatable across platforms.
Several workflow management systems, such as Nextflow, 
Toll and Galaxy, have recently been reported as having the 
capacity to use and deploy containers. These tools all share the 
same philosophy: they make it relatively easy to define and 
implement new pipelines, and they provide more or less 
extensive support for the massively parallel deployment of 
these pipelines across high performance computational (HPC) 
infrastructures or over the cloud.
Containerization also provides a very powerful way of 
distributing tools in production mode. This makes it an 
integral part of the ongoing effort to standardise genome analy-
sis tools. The wide availability of public software repositories, 
such as GitHub or Docker Hub provides a context in which the 
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implementation of existing standards bring immediate 
benefits to the analysis, both in terms of costs, repeatability and 
dissemination across a wide variety of environments.
The choice of a workflow manager and the proper 
integration of the selected pipelines through a well thought con-
tainerization strategy can therefore be considered an integral 
part of the genome annotation process, especially if one expects 
annotation to keep being updated over time. This makes 
the adoption of good computational practices like the one 
described here an essential milestone for genomic analysis to 
become compliant with the new data paradigm. In order to carry 
this out, the first guidelines to make data “findable, accessible, 
interoperable and re-usable” (FAIR)68 was published in 2016. 
Even if FAIR principles were originally focused on data, 
they are sufficiently general so these high level concepts can be 
applied to any Digital Object such as software or pipelines.
Repeatability is merely the most technical side of 
reproducibility. Reproducibility is a broader concept that encom-
passes any decision and bookkeeping procedure that could 
compromise the reproducibility of an established scientific 
result. For this reason the implementation of the FAIR principle 
also impacts higher level aspect of the genome annotation strat-
egy and for a genomic project to be FAIR compliant, these good 
practices should be applied to both data, meta-data and software. 
This can be achieved as follows:
Data and meta-data
Findable: Globally unique and persistent identifiers for 
data and metadata. Identifiers should persist across release and 
make it possible to trace back older analysis and relate them to 
the current annotation. Deprecated annotation should remain 
traceable. Even when data is not any longer available, meta-data 
should remain and provide a description of the original data.
Accessible: Proper registration of data and metadata in suit-
able public, or self-maintained repository. All data should be 
properly indexed and searchable and accessible by identifier using 
standardized protocols
Interoperable: Data and meta-data must be deposited using the 
most commonly used format
Reusable: Data and meta-data standards should insure that 
the data is sufficiently well characterized to be effectively 
reused in future analysis or to be challenged by novel evaluation 
methods. Licensing should be as little restrictive as possible.
Software and pipelines
Findable: Software and pipelines should be deposited in an 
open source registries along with proper technical descriptions 
allowing their rapid identification.
Accessible: Software should be deposited in public repositor-
ies such as GitHub, Docker Hub, so as to be available. Attempts 
should be made at having the licensing as little restrictive 
as possible. ELIXIR has taken the challenge to provide a long-term 
sustainable infrastructure to host software containers. Thus, this 
is the desirable solution to ensure software accessibility.
Interoperable: Software should use the most common 
format and should be adequately documented. It should come 
along with a proper versioning for both the software and the refer-
ence biological databases they operate upon. The software behav-
ior should also be adequately described using the right metadata, 
thus allowing programmatic interaction with other resources.
Reusable: Software should be distributed in open-source format 
so as to ensure possible long term maintenance by third parties. 
Software should be encapsulated within containers ensuring 
the permanent availability of production mode pipelines. Authors 
should be encouraged to develop their pipelines in commonly 
used workflow managers (Galaxy69, Nextflow70, Snakemake71). 
Decisions should be taken on the basis of a compromise between 
the level of usage of the selected workflow and its support 
of the required features. It should also contain meta-data describ-
ing which parameters have been used with the software in order 
to guarantee data reproducibility.
10. Investigate, re-analyse, re-annotate
Successful genome annotation projects do not just end 
with the publication of a paper; they should produce sustainable 
resources to promote, extend and improve the genome annotation 
life cycle.
Some genome consortia choose to manually review and 
edit their annotation data sets via jamborees, for instance 
the BioInformatics Platform for Agroecosystem Arthropods. 
Although this process is time- and resource-intensive, it provides 
opportunities for community building, education and training. 
All these elements help to improve the annotation life cycle and 
are promoted by the International Society for Biocuration.
Manual and continuous annotation are critical to achieve 
accurate and reliable gene models, mRNA, TEs, regulatory 
sequences, among other elements. In addition, research com-
munities will face the generation of a huge volume of new 
data including re-sequencing, transcriptomics, transcriptional 
regulation profiling, epigenetic studies, high-throughput geno-
typing and other related whole-genome functional studies. Thus, 
it is important to provide a software infrastructure to facilitate 
the updating of the genomic data.
Tools such as WebApollo72 from the GMOD project or 
web-portals like ORCAE73 are particularly useful. These tools 
allow groups of researchers to review, add and delete annota-
tions in a collaborative approach. The applications are robust and 
flexible enough to allow the members of a group to work simul-
taneously or at different times. The administration of the server 
allows to initiate a session to a user and if it has the authorization, 
to edit the content.
Thanks to this system, annotations of genomes can be 
improved in a continuous cycle as data is collected and updated. 
In this way the annotations can always continue to improve.
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   Dave Clements
Department of Biology, Johns Hopkins University, Baltimore, MD, USA
This paper does a good job of covering the big picture of what's needed to assemble and annotate a
genome.  Its stated goal is to give guidelines that are "broadly applicable" and "intended to be stable over
time."   This paper achieves that goal, and all of my concerns are minor.  However, "stable over time" was
a frustrating goal for me.  This means that comments on specific sequencing technologies and software
are not as common as they would be in a review article on the state of the art.  This is a fine line to walk.
Specific comments
Introduction
1. Think about dropping or shortening the checklist at the end of the introduction.  I believe that all of this
is covered in detail in the individual sections.
Repeats
1. "Contigs" used for the first time,  Not sure if these need to be explained.  (Could reference figure 3.)
Chemical purity
1. What ONT means is explained later.  Move that explanation here.
2. The text says:
  It is widely known in the PacBio community that samples rich in contaminants...
Are there any references for this?  This highlights a larger question with the paper.  It is an   articleopinion
and it contains many opinions such as 
  The characteristics of the genomes being assembled have a greater impact on the results than the
choice of the algorithm.
I am not disputing any of these statements, but if and when references exist that support them, then those
references should be included.
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 references should be included.
Long read genome assembly
This section says error rates are 5-20%.  Elsewhere in the paper they are given as "up to 10% or 15%."
Scaffolding and gap filling
The very end of this section states:
  Be aware that any changes to a genome assembly will most likely necessitate annotation to be
re-started from scratch, and you should therefore be sure to “freeze” the assembly completely before
starting annotation.
I think "restarted from scratch" gives the wrong impression.  Tools such as MAKER can do liftover from
one version of an assembly to the next.  Perhaps this could be clarified?
Ensure your methods are computationally repeatable and reproducible
Toll -> Toil ?
Is the topic of the opinion article discussed accurately in the context of the current literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Are arguments sufficiently supported by evidence from the published literature?
Partly
Are the conclusions drawn balanced and justified on the basis of the presented arguments?
Yes
 No competing interests were disclosed.Competing Interests:
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 09 March 2018Referee Report
doi:10.5256/f1000research.14771.r31487
   Bruno Contreras-Moreira
Estación Experimental de Aula Dei-CSIC, Fundación ARAID, Zaragoza, Spain
The opinion article by Victoria Dominguez Del Angel and collaborators is a well-written sort of broad
tutorial which will certainly be of help for anyone trying to sequence and assemble a genome sequence
with little previous experience. While it avoids details that are required when the real work is actually
carried out (for instance, K-mer length), it discusses important questions that must be addressed before
carrying out genomic projects, and choices that must be made along the way down to the point that data
and procedures are published and released.
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 and procedures are published and released.
Next I comment on specific parts of the text that I believe can be improved.
0. Introduction
0.1 Genomics in 2018 cannot possibly be done without a pan-genome perspective. This has been true for
years in the area of microbiology, where projects now rarely assemble and annotate a single genome, but
rather a few dozens related strains. In addition, this is becoming state-of-the-art also for genomic projects
of crops and model plants, such as  , as well as in human medicine. A couple ofBrachypodium distachyon
sentences should be added explaining that in this context a group of genomes are sequences, assembled
and annotated in parallel, which makes it more challenging but also facilitates spotting and correcting
errors.
0.2 I would add to the checklist a literature survey to identify related genomes.
1. Investigate the properties of the genomes you study
1.1 Heterozygosity
I would add a sentence about the outcrossing or selfing nature of species, which has a direct impact on
the expected heterozygosity, and often limits the possibility to obtain inbred individuals. In plants
double-haploids are used to this end (see for instance  .
1.2 Ploidy level
Please note that it has been estimated that many plant species are polyploid  . One strategy to solve
these complex genomes is to first sequence the genomes of the expected/known parental species.
2. Extract high quality DNA
2.1 Organelle DNA
I would add that frequently chloroplast genomes or plastomes are of high interest as they can provide a
complementary, maternally-biased evolutionary history. This might be of particular interest for polyploid
species as it might help determine which was the maternal and which the paternal genome donor. Even
with a low ratio of organelle DNA in our experience is likely that complete chloroplasts can be assembled
and annotated (see for instance  ) as a by-product of whole genome sequencing. Instead, mitochondria
seem to be difficult to assemble in plants.
4. Estimate the necessary computational resources
I would add that the assembly tools selected at the time the proposal was written are likely to be replaced
by others when the work is actually to be performed due to pace of innovation in this area.
5. Assemble your genome
In the last left-side paragraph it is said that “misassemblies in an existing assembly need to be broken
prior to scaffolding in order to join the correct contigs together.” . This is followed by another sentence
later on “Unfortunately, there are few ways to distinguish what is real, what is missing, and what is an
experimental artefact.”
1
2-3
4
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 experimental artefact.”
In our experience many scaffolding errors can be spotted by mapping back the original sequence reads to
the assembly and then visualizing the results with browsers such as IGV. Of course this can be
cumbersome for very large assemblies, but tools such as SEQuel and Reapr can be really helpful for such
tasks.
5.1 BUSCO is shown as a way of evaluating assembly quality in page 10.
I would add that in pan-genome projects this can be generalized so that assemblies, and subsequent
annotations, can be evaluated in terms of the proportion of core-genes contained. Poor assemblies can
be identified frequently for having less core-genes than expected.
7. Annotate genes with high quality experimental evidence
I feel this section can be improved by:
7.1 Stressing that different annotation strategies often yield annotation sets that are implicitly biased.
Therefore, if the user plans to compare its genome to others should make and effort to use a similar
approach so that any conclusions regarding issues such as gene family expansions are not caused by the
underlying methodology. Indeed we have seen this happening when annotating a microbial pan-genome
and then comparing it to genomes in public databases.
7.2 Adding a section on microbial genome annotation, mentioning popular tools such as PROKKA, RAST
or NCBI Prokaryotic Genome Annotation Pipeline, and commenting on the annotation of bacterial features
such as CRISPRs or plasmids.
7.3 On page 12, 1  paragraph, is its stated that “Transcripts on the other hand provide very accurate
information for the correct prediction of the genes”
I think it should definitely be mentioned that, unlike HQ protein sequences, transcripts allow the
annotation of unstranslated regions (UTR) and despite their noise and the isoform deluge can be used to
define also gene promoters, which can then be annotated in terms of regulation.
7.4 I miss a section on comparison of gene order/synteny
8. Use well-established output formats and submit your data to suitable repositories
I would add that soft/hard repeat-masked versions of the genome sequence can be made available in
FASTA format, which are helpful for subsequent analyses of regulatory sequences.
Minor edits:
Page 3, 1  paragraph:
“The advice here presented is based on a need seen while working in the ELIXIR-EXCELERATE task
“Capacity Building in Genome Assembly and Annotation”. In this capacity we have”
can be changed to
“The advice here presented is based on a need first seen while working in the ELIXIR-EXCELERATE task
“Capacity Building in Genome Assembly and Annotation”. In this project we have”
st
st
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 “Capacity Building in Genome Assembly and Annotation”. In this project we have”
Page 6, 2  paragraph
Why is “or after” in bold?
Page 14, left column
Fasta format should be FASTA format
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